GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Net Income From Continuing Operations

Achiko AG (Achiko AG) Net Income From Continuing Operations : $-6.86 Mil (TTM As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Achiko AG's net income from continuing operations for the six months ended in Jun. 2022 was $-2.50 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2022 was $-6.86 Mil.


Achiko AG Net Income From Continuing Operations Historical Data

The historical data trend for Achiko AG's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Net Income From Continuing Operations Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Net Income From Continuing Operations
- -7.32 -14.07 -9.32

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Net Income From Continuing Operations Get a 7-Day Free Trial -5.04 -9.03 -4.96 -4.36 -2.50

Achiko AG Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-6.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Achiko AG (Achiko AG) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (Achiko AG) Headlines

From GuruFocus

Achiko AG Obtains CE Mark for AptameX� Covid-19 Rapid Test

By GuruFocusNews GuruFocusNews 07-06-2022

Achiko AG Announces Corporate Update Webcast

By Value_Insider Value_Insider 11-16-2022

Achiko AG Obtains CE Mark for AptameX� Covid-19 Rapid Test

By GuruFocusNews GuruFocusNews 06-26-2022

Achiko AG � Suspension of Trading

By GuruFocusNews GuruFocusNews 06-28-2022

Achiko AG � Suspension of Trading

By GuruFocusNews GuruFocusNews 07-08-2022